CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 97 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $191,921 | -79.5% | 6,085 | -81.7% | 0.00% | -80.0% |
| Q3 2022 | $938,000 | +241.1% | 33,207 | +291.3% | 0.01% | +66.7% |
| Q4 2021 | $275,000 | -47.6% | 8,486 | -52.3% | 0.00% | -57.1% |
| Q3 2021 | $525,000 | +17400.0% | 17,809 | +17709.0% | 0.01% | – |
| Q2 2021 | $3,000 | -40.0% | 100 | -75.0% | 0.00% | – |
| Q1 2021 | $5,000 | -97.5% | 400 | -96.7% | 0.00% | -100.0% |
| Q4 2020 | $201,000 | – | 12,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |